THERAPEUTIC AREA: Neurosciences + Rare Diseases ACTIVE PRINCIPLE: Human Normal Immunoglobulin (IgSC) PRESENTATION: 10 and 20 mg vials: containers of 1, 10 or 20 units INDICATION:
COUNTRIES WHERE IT IS MARKETED: